• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼群地平——一种新型钙拮抗剂——治疗高血压的经验。

Experience with nitrendipine--a new calcium antagonist--in hypertension.

作者信息

Andrén L, Hansson L, Orö L, Ryman T

出版信息

J Cardiovasc Pharmacol. 1982;4 Suppl 3:S387-91. doi: 10.1097/00005344-198200433-00025.

DOI:10.1097/00005344-198200433-00025
PMID:6184574
Abstract

The antihypertensive effect of 20 mg of nitrendipine (BAY e 5009) was compared with that of 40 mg, administered orally once daily to 12 patients with essential hypertension (WHO I-II). The study was designed as a double-blind, within-patient comparison. The present results indicate that nitrendipine has a significant antihypertensive effect both at 20 and 40 mg as compared to placebo. There was no significant change in heart rate with 20 mg of nitrendipine, whereas there was a significant increase in heart rate after the first dose of 40 mg. Nitrendipine in dosages of 20 mg and 40 mg daily was equally effective as regards the antihypertensive effect. This applies both to the early response (first day) and the late response (3 weeks). Side effects were common in the 40-mg treatment group, but rare in the 20-mg group; only one patient had headache (three times) during the 3-week treatment period. It can be concluded that in mild hypertension, treatment with 20 mg of nitrendipine once daily constitutes an effective antihypertensive therapy. In more severe cases of hypertension, however, combination treatment with beta-blockers, for example, and/or repeated daily administration of nitrendipine ought to be investigated.

摘要

将20毫克尼群地平(BAY e 5009)的降压效果与40毫克尼群地平进行比较,对12例原发性高血压(WHO I-II级)患者每日口服给药一次。该研究设计为双盲、患者自身对照研究。目前的结果表明,与安慰剂相比,20毫克和40毫克尼群地平均具有显著的降压效果。服用20毫克尼群地平后心率无显著变化,而服用首剂40毫克后心率显著增加。每日服用20毫克和40毫克尼群地平的降压效果相同。这在早期反应(第一天)和晚期反应(3周)中均适用。副作用在40毫克治疗组中常见,但在20毫克组中罕见;在3周治疗期间,只有1例患者出现头痛(3次)。可以得出结论,在轻度高血压中,每日一次服用20毫克尼群地平构成有效的降压治疗。然而,在更严重的高血压病例中,应研究例如与β受体阻滞剂联合治疗和/或每日重复给药尼群地平。

相似文献

1
Experience with nitrendipine--a new calcium antagonist--in hypertension.尼群地平——一种新型钙拮抗剂——治疗高血压的经验。
J Cardiovasc Pharmacol. 1982;4 Suppl 3:S387-91. doi: 10.1097/00005344-198200433-00025.
2
Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.硝苯地平与肼屈嗪作为单一抗高血压药物的疗效及安全性比较
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1109-13. doi: 10.1097/00005344-198400067-00035.
3
Acute and short-term effects of new calcium antagonist in hypertension.新型钙拮抗剂在高血压治疗中的急性和短期效应
Hypertension. 1982 May-Jun;4(3 Pt 2):32-5.
4
Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.尼群地平和阿替洛尔:治疗动脉高血压的比较与联合应用
Arzneimittelforschung. 1985;35(4):727-9.
5
Pharmacokinetic and pharmacodynamic parameters in patients treated with nitrendipine.
Hypertension. 1983 Jul-Aug;5(4 Pt 2):II25-8. doi: 10.1161/01.hyp.5.4_pt_2.ii25.
6
Muzolimine and nitrendipine in the treatment of arterial hypertension.
Z Kardiol. 1985;74 Suppl 2:60-5.
7
Clinical experience with long-term nitrendipine treatment in essential hypertension.硝苯地平长期治疗原发性高血压的临床经验。
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1090-5.
8
Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.硝苯地平与普萘洛尔在原发性高血压患者中的交叉对照研究。
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1100-4.
9
Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension.
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1096-9.
10
Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.尼群地平联合小剂量氢氯噻嗪与单用氢氯噻嗪治疗轻至中度原发性高血压的比较。
J Cardiovasc Pharmacol. 1984;6 Suppl 7:S1105-8.

引用本文的文献

1
Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.尼群地平。对其药效学和药代动力学特性以及治疗高血压的疗效的综述。
Drugs. 1987 Feb;33(2):123-55. doi: 10.2165/00003495-198733020-00003.
2
Treatment of essential hypertension with felodipine in combination with a diuretic.
Eur J Clin Pharmacol. 1986;30(2):133-9. doi: 10.1007/BF00614290.
3
Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy.关于钙通道阻滞剂尼群地平对人类妊娠早期影响的一些观察。
Br J Clin Pharmacol. 1987 Jun;23(6):683-92. doi: 10.1111/j.1365-2125.1987.tb03102.x.
4
The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine.口服钙拮抗剂硝苯地平和尼群地平后的利钠作用。
Br J Clin Pharmacol. 1985 Apr;19(4):423-7. doi: 10.1111/j.1365-2125.1985.tb02665.x.
5
Relative potency of a beta-blocking and a calcium entry blocking agent as antihypertensive drugs in black patients.β受体阻滞剂和钙通道阻滞剂作为降压药物在黑人患者中的相对效价。
Eur J Clin Pharmacol. 1986;29(5):523-7. doi: 10.1007/BF00635887.
6
Calcium channel antagonists: Part VI: Clinical pharmacokinetics of first and second-generation agents.钙通道拮抗剂:第六部分:第一代和第二代药物的临床药代动力学
Cardiovasc Drugs Ther. 1989 Aug;3(4):482-97. doi: 10.1007/BF01865507.
7
Calcium-channel blockers and sodium intake: a controlled study in patients with essential hypertension.钙通道阻滞剂与钠摄入:对原发性高血压患者的一项对照研究。
Cardiovasc Drugs Ther. 1989 Apr;3(2):135-40. doi: 10.1007/BF01883856.
8
Nitrendipine therapy in asthmatic subjects.尼群地平治疗哮喘患者。
Br J Clin Pharmacol. 1990 Sep;30(3):493-5. doi: 10.1111/j.1365-2125.1990.tb03804.x.